SCHEMBL1127874

SCHEMBL1127874

NNC(=O)[AsH]CC1CCC(OC(=O)OC(=O)C(F)(F)F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL939950 0.79 TDP1 (0.37)
Trifluoroacetic Acid SCHEMBL1127872 0.74 PLG (0.42)
SCHEMBL1419796 0.69 EPHX1 (0.40)
SCHEMBL26626499 0.65 PLG (0.42)
SCHEMBL20240947 0.65 PLG (0.42)
SCHEMBL1958023 0.64 NAAA (0.31)
Hydrazine SCHEMBL22505628 0.63 GPR35 (0.33)
SCHEMBL398217 0.62 GPR35 (0.34)
SCHEMBL6294396 0.62 TDP1 (0.39)
SCHEMBL19924308 0.61 PLG (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2283022-A1 FURO Ý3, 2-B¨PYRR0L-3-0NES AS CATHEPSIN S INHIBITORS Amura Therapeutics Limited (GB) 2011-02-16 EP disclosed
WO-2009112826-A1 FURO [3, 2-B] PYRR0L-3-0NES AS CATHEPSIN S INHIBITORS AMURA THERAPEUTICS LIMITED (GB) 2009-09-17 WO disclosed